Noradrenergic function in obsessive-compulsive disorder: Behavioral and neuroendocrine responses to clonidine and comparison to healthy controls
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
To evaluate noradrenergic (NE) function in obsessive-compulsive disorder (OCD), behavioral, physiological, and neuroendocrine responses to the alpha 2-adrenergic agonist clonidine were examined in 18 patients with OCD and 10 healthy subjects. Subjects received single i.v. doses of 2 micrograms/kg of clonidine administered under double-blind, placebo-controlled, random-assignment conditions. Following clonidine, but not following placebo, patients transiently experienced a significant reduction of obsessions and compulsions. Significant drowsiness and a reduction in anxiety were also noted, but the antiobsessional effect appeared independent of the soporific and antianxiety effects. Growth hormone (GH), cortisol, and 3-methoxy-4-hydroxyphenylglycol responses to clonidine did not differentiate patients from healthy controls. Blood pressure and pulse in response to clonidine did not differ between groups. Improvement in OCD symptoms after clonidine significantly correlated with GH response to clonidine, suggesting specific noradrenergic mediation. This finding lends only partial support for a primary defect of noradrenergic function in OCD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550
Clinical characteristics and family history in DSM-III obsessive- compulsive disorder
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.3.317 · Cited by 668
Charney, D. S. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790190025003 · Cited by 599
Clomipramine Treatment of Obsessive-Compulsive Disorder: I. A Controlled Clinical Trial
Thorén, P. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780240079009 · Cited by 497
Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder: A Double-blind Controlled Study
Flament, M. F. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790330057007 · Cited by 466
Cited by
Chamberlain, S. R., Blackwell, A. D., Fineberg, N. A., Robbins, T. W., & Sahakian, B. J. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.11.006 · Cited by 830
“Given that the alpha-2 adrenergic agonist clonidine has been shown to reduce symptom severity in OCD (Knesevich, 1982; Hollander et al., 1991), noradrenergic dysfunction may also be important, though there is a lack of evidence that noradrenergic selective reuptake inhibitors are effective at ameliorating symptoms.”
Probing compulsive and impulsive behaviors, from animal models to endophenotypes: A narrative review
Fineberg, N. A., Potenza, M. N., Chamberlain, S. R., Berlin, H. A., Menzies, L., Bechara, A., Sahakian, B. J., Robbins, T. W., Bullmore, E. T., & Hollander, E. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.185 · Cited by 654
“In OCD patients, acute pharmacological challenge with mCPP exacerbated OCD symptomatology (Hollander et al, 1991b).”
BackgroundSelf-citationNoradrenergic mechanisms in stress and anxiety: I. preclinical studies
Bremner, J. D., Krystal, J. H., Southwick, S. M., & Charney, D. S. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199605)23:1<28::aid-syn4>3.0.co;2-j · Cited by 594
Leckman, J. F., Goodman, W. K., Anderson, G. M., Riddle, M. A., Chappell, P. B., McSwiggan-Hardin, M. T., McDougle, C. J., Scahill, L. D., Ort, S. I., Pauls, D. L., et al. (1995) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380241 · Cited by 169
Niehaus, D. J. H., Kinnear, C. J., Corfield, V. A., du Toit, P. L., van Kradenburg, J., Moolman-Smook, J. C., Weyers, J. B., Potgieter, A., Seedat, S., Emsley, R. A., et al. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00246-9 · Cited by 54
Metadata
- Authors
- Hollander, E., DeCaria, C., Nitescu, A., Cooper, T., Stover, B., Gully, R., Klein, D. F., & Liebowitz, M. R.
- Venue
- Psychiatry Research
- Publisher
- Elsevier BV
- Published
- 1991-05
- Volume
- 37
- Issue
- 2
- Pages
- 161-177
- ISSN
- 0165-1781 (ISSN-L)
- OpenAlex
- W1977407356
- Cited by
- 73
- References
- 6
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Noradrenergic function in obsessive-compulsive disorder: Behavioral and neuroendocrine responses to clonidine and comparison to healthy controls. https://app.cochat.ai/papers/10.1016/0165-1781(91)90073-x
- The paper
- Hollander, E., DeCaria, C., Nitescu, A., Cooper, T., Stover, B., Gully, R., Klein, D. F., & Liebowitz, M. R. (1991). Noradrenergic function in obsessive-compulsive disorder: Behavioral and neuroendocrine responses to clonidine and comparison to healthy controls. Psychiatry Research. https://doi.org/10.1016/0165-1781(91)90073-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.